# A Study to Investigate the Relative Bioavailability and Food Effect of an Oral Capsid Inhibitor Tablet Formulation Compared With Other Oral Tablet Formulations in Male and Female Healthy Participants

> **NCT06168318** · PHASE1 · COMPLETED · sponsor: **ViiV Healthcare** · enrollment: 46 (actual)

## Conditions studied

- HIV Infections

## Interventions

- **DRUG:** VH4004280 Formulation A
- **DRUG:** VH4004280 Formulation B
- **DRUG:** VH4004280 Formulation C
- **DRUG:** VH4004280 Formulation D
- **DRUG:** VH4004280 Formulation E

## Key facts

- **NCT ID:** NCT06168318
- **Lead sponsor:** ViiV Healthcare
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-12-18
- **Primary completion:** 2024-06-03
- **Final completion:** 2024-06-03
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2024-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06168318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06168318, "A Study to Investigate the Relative Bioavailability and Food Effect of an Oral Capsid Inhibitor Tablet Formulation Compared With Other Oral Tablet Formulations in Male and Female Healthy Participants". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06168318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*